M/13/021 – Aspen / MSD NL 8 B.V.
Transaction details
The acquisition of MSD NL 8 B.V. (a subsidiary of Merck & Co Incorporated) by Aspen Pharmacare Holdings Limited has been cleared by the Competition Authority.
| Notification date | Decision date |
|---|---|
| Thursday July 18, 2013 | Wednesday, August 14, 2013 |
| Parties Involved | Business activities |
|---|---|
| Aspen Pharmacare Holdings Limited | Aspen is a globally competitive producer of high quality affordable generic medicines and is involved in the development, registration, manufacture, import, marketing, selling and distribution of pharmaceutical products. |
| MSD NL 8 B.V. | MSD BV is comprised of the API manufacturing business which manufactures unprocessed APIs both for Merck and Co Incorporated and the market generally. |
| Economic sector | Media merger |
|---|---|
| The pharmaceutical industry | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Monday, July 29, 2013 | |
| Current status: Completed |
|---|
| Cleared (Phase 1) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Andrew Rae | Tel: 01-804 5420 |
Media enquiries: MKC Communications: 01 7038600
Haven’t found what you’re looking for?
Scroll
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555